Real-world safety of aliskiren in primary hypertension: A cross-database study.

Shan M, Guo Q, Li R, Li N, Fu Y, Qi H, Zhang G, Wang Q, Xu X, Lai J

DOI: 10.1371/journal.pone.0346326
Published: 2026
Container: PloS one
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1371/journal.pone.0346326,
  title = {Real-world safety of aliskiren in primary hypertension: A cross-database study.},
  author = {Shan M and Guo Q and Li R and Li N and Fu Y and Qi H and Zhang G and Wang Q and Xu X and Lai J},
  year = {2026},
  journal = {PloS one},
  doi = {10.1371/journal.pone.0346326},
  url = {https://doi.org/10.1371/journal.pone.0346326}
}

RIS

TY  - JOUR
TI  - Real-world safety of aliskiren in primary hypertension: A cross-database study.
AU  - Shan M
AU  - Guo Q
AU  - Li R
AU  - Li N
AU  - Fu Y
AU  - Qi H
AU  - Zhang G
AU  - Wang Q
AU  - Xu X
AU  - Lai J
PY  - 2026
JO  - PloS one
DO  - 10.1371/journal.pone.0346326
UR  - https://doi.org/10.1371/journal.pone.0346326
ER  -

APA

M, S., Q, G., R, L., N, L., Y, F., H, Q., G, Z., Q, W., X, X., & J, L. (2026). Real-world safety of aliskiren in primary hypertension: A cross-database study.. PloS one. https://doi.org/10.1371/journal.pone.0346326

Source records

pubmed · retrieved 2026-09-25T10:18:13.227Z